Α low-dose of dexamethasone improves survival in patients with severe COVID-19 disease, ANA reports.
Efstathios Kastritis, Associate Professor of the Therapeutic Clinic of the Medical School of the National and Kapodistrian University of Athens (NKUA), and Professor of Therapeutic and Rector of NKUA Thanos Dimopoulos summarized the finds of the RECOVERY clinical study launched in the United Kingdom in March 2020 aiming at trying a series of possible treatments for COVID 19. The study included over 11,500 patients in over 175 hospitals in the UK’s National Health Service (NHS).
Dexamethasone is a form of cortisone, which has been used for many decades in many diseases and has a strong anti-inflammatory effect.
RELATED TOPICS: Greece, Greek tourism news, Tourism in Greece, Greek islands, Hotels in Greece, Travel to Greece, Greek destinations, Greek travel market, Greek tourism statistics, Greek tourism report
Photo Source: pixabay.com
